We recently completed Phase 2 studies of our lead candidate, zervimesine (CT1812) in dementia with Lewy bodies (DLB), mild-to-moderate Alzheimer’s disease and geographic atrophy secondary to dry ...

Cognition Therapeutics plans a Phase 2 meeting with FDA for zervimesine in Alzheimer's disease and submitted applications for DLB. Cognition Therapeutics, Inc. announced an upcoming end-of-Phase 2 ...

Think gaming's just for grandkids? Think again. It could sharpen your brain, boost your mood, and keep you socially plugged ...

Why shouldn’t Matthew Lim play Winnie? Inside his body, the role would be no spoof at all but the purest of incarnations.

A woman's estimated lifetime risk of developing Alzheimer's at age 65 is 1 in 6, compared with nearly 1 in 11 for a man. Worldwide, nearly 44 million people are believed to be living with ...

Anna Wintour stepping down as Vogue editor-in-chief, but will retain editorial control over the storied magazine.

Wintour informed staff about the change, which aligns with Condé Nast’s global reorganization of editorial teams.